We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Bioprinting 3D Technology Mimics Liver to Detoxify Blood

By LabMedica International staff writers
Posted on 27 May 2014
Print article
Image: Nanoengineers have developed a 3D printed device inspired by the liver to remove dangerous toxins from the blood. The device, which is designed to be used outside the body like dialysis, uses nanoparticles to trap pore-forming toxins that can damage cellular membranes and are a key factor in illnesses that result from animal bites and stings, and bacterial infections (Photo courtesy of UCSD – the University of California, San Diego).
Image: Nanoengineers have developed a 3D printed device inspired by the liver to remove dangerous toxins from the blood. The device, which is designed to be used outside the body like dialysis, uses nanoparticles to trap pore-forming toxins that can damage cellular membranes and are a key factor in illnesses that result from animal bites and stings, and bacterial infections (Photo courtesy of UCSD – the University of California, San Diego).
Nanoengineers have developed a three-dimensional (3D)-printed device to act like the liver to remove harmful toxins from the blood. The device, which is designed to be used outside the body, similar to dialysis, utilizes nanoparticles to trap pore-forming toxins that can injure cellular membranes and are a major factor in disorders that result from stings, animal bites, and bacterial infections.

The study’s findings were published May 8, 2014, in the journal Nature Communications. Nanoparticles have already been shown to be effective at neutralizing pore-forming toxins in the blood, but if those nanoparticles cannot be effectively digested, they can accumulate in the liver creating a risk of secondary poisoning, particularly among patients who are already at risk of liver failure. To resolve this problem, a team of investigators, led by University of California, San Diego’s (UCSD; USA) nanoengineering Prof. Shaochen Chen devised a 3D-printed hydrogel matrix to hold nanoparticles, forming a device that mimics the function of the liver by sensing, attracting, and capturing toxins channeled from the blood.

The device, which is in the proof-of-concept phase, replicates the structure of the liver but has a larger surface area designed to effectively lure and trap toxins within the device. In an in vitro study, the device totally neutralized pore-forming toxins. “One unique feature of this device is that it turns red when the toxins are captured,” said the co-first author, Xin Qu, who is a postdoctoral researcher working in Prof. Chen’s laboratory. “The concept of using 3D printing to encapsulate functional nanoparticles in a biocompatible hydrogel is novel,” said Prof. Chen. “This will inspire many new designs for detoxification techniques since 3D printing allows user-specific or site-specific manufacturing of highly functional products.”

Prof. Chen’s lab has already validated the ability to print complex 3D microstructures, such as blood vessels, in only seconds out of soft biocompatible hydrogels that contain living cells.

Related Links:

University of California, San Diego


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.